The relationship between clinicopathological parameters and PD-L1 expression level in advanced stage non-small cell lung cancer

Creative Commons License

Gurbuz M., DOĞAN İ., AKKUŞ E., ÖZAKINCI H., Tolunay P. K., KALACI E., ...More

TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, vol.70, no.2, pp.132-140, 2022 (ESCI) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 70 Issue: 2
  • Publication Date: 2022
  • Doi Number: 10.5578/tt.20229803
  • Journal Name: TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, CAB Abstracts, EMBASE, MEDLINE, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.132-140
  • Keywords: Programmed cell death ligand 1, non-small cell lung cancer, clinicopathological parameters, immunotherapy, LIGAND 1 EXPRESSION, ASSOCIATION, FEATURES
  • Open Archive Collection: AVESIS Open Access Collection
  • Istanbul University Affiliated: No

Abstract

Introduction: Clinicopathological parameters related to programmed death ligand 1 (PD-L1) expression levels have been investigated in several studies. However, the results of these studies are conflicting and vary in different populations. This study aimed to investigate the relation of clinicopathological parameters with PD-L1 expression level in advanced stage non-small cell lung cancer patients.